Skip to main content
Year archive

Karolinska Development — 2018 filings

All 34 regulatory filings released by Karolinska Development (KDEV) in 2018, sourced directly from the official regulator.

34 Filings
2018 Period
2018 filings (34)
Filing Released Lang
Major Shareholding Notification 2018
Major Shareholding Notification
2018-12-03 English
SEK 512 miljoner finansiering genomförd i Karolinska Developments portföljbolag Aprea Therapeutics
Capital/Financing Update
2018-11-30 Swedish
Financing of SEK 512 million secured in Karolinska Development's portfolio company Aprea Therapeutics
Capital/Financing Update
2018-11-30 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-29 English
Investor Presentation 2018
Investor Presentation
2018-11-13 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q3 2018
2018-11-13 English
Karolinska Development's portfolio company Dilafor presents top line results from a Phase 2b study with tafoxiparin
Regulatory Filings
2018-10-31 English
Karolinska Developments portföljbolag Dilafor presenterar övergripande resultat från en fas 2b studie med tafoxiparin
Regulatory Filings
2018-10-31 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-08-22 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q2 2018
2018-08-16 Swedish
Investor Presentation 2018
Investor Presentation
2018-08-16 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-08-14 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-08-10 English
HealthCap investerar i Karolinska Developments portföljbolag Modus Therapeutics
Share Issue/Capital Change
2018-07-13 Swedish
HealthCap invests in Karolinska Development's portfolio company Modus Therapeutics
M&A Activity
2018-07-13 English
Change of Number of Shares and Votes in Karolinska Development
Share Issue/Capital Change
2018-06-29 English
Ändring av antal aktier och röster i Karolinska Development
Share Issue/Capital Change
2018-06-29 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-30 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-28 English
Karolinska Developments årsstämma 2018
AGM Information
2018-04-26 Swedish
Karolinska Development's Annual General Meeting 2018
AGM Information
2018-04-26 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-25 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-25 English
Karolinska Development's portfolio company Aprea presents initial results from the ongoing phase Ib/II study with APR-246 and azacitidine for the treatment of Mutant Myelodysplastic Syndromes
Regulatory Filings
2018-04-16 English
Karolinska Developments portföljbolag Aprea presenterar initiala resultat från den pågående fas Ib/II-studien med APR-246 och azacitidine för behandling av muterat myelodysplastiskt syndrom
Earnings Release FY 2018
2018-04-16 Swedish
Karolinska Development säljer kvarvarande aktier i BioArctic
M&A Activity
2018-04-13 Swedish
Karolinska Development sells remaining shares in BioArctic
Transaction in Own Shares
2018-04-13 English
Annual Report 2017
Annual Report FY 2017
2018-03-21 Swedish
Annual Report 2017
Annual Report FY 2017
2018-03-21 English
Notice of Annual General Meeting in Karolinska Development AB (publ)
AGM Information
2018-03-21 English
Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma
AGM Information
2018-03-21 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q4 2017
2018-02-15 Swedish
Earnings Release 2017
Earnings Release Q4 2017
2018-02-15 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-01-26 English